Advanced search
Publication Cover
Current Medical Research and Opinion Volume 31, 2015 - Issue 9
Submit an article Journal homepage
960
Views
12
CrossRef citations to date
0
Altmetric
Brief review

Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review

Andrew J. PeacockScottish Pulmonary Vascular Unit, Regional Heart and Lung Centre, Glasgow, UKCorrespondence[email protected]
,
William ZamboniEuropean Immunology and Rare Diseases Unit, GlaxoSmithKline SpA, Verona, Italy
&
Carmine Dario VizzaPulmonary Hypertension Unit, Department of Cardiovascular and Respiratory Disease, Sapienza University of Rome, Rome, Italy
Pages 1793-1807 | Accepted 17 Jul 2015, Published online: 21 Jul 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marco Barbieri, Stefano Ghio, Michele D’Alto, Carlo Albera, Renato Carignola, Massimiliano Mulè, Patrizio Vitulo, Miriam Vighini, Rosaria Silvestri, William Zamboni & Carmine Dario Vizza. (2018) Initial combination therapy for patients with pulmonary arterial hypertension (PAH): a budget impact analysis from the perspective of the Italian national healthcare system. Expert Opinion on Orphan Drugs 6:1, pages 1-7.
Read now

Articles from other publishers (11)

Adriana Torres Crigna, Barbara Link, Marek Samec, Frank A. Giordano, Peter Kubatka & Olga Golubnitschaja. (2021) Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine. EPMA Journal 12:3, pages 265-305.
Crossref
Gerald J. Maarman, Jane Shaw & Brian Allwood. (2020) Pulmonary hypertension in majority countries: opportunities amidst challenges. Current Opinion in Pulmonary Medicine 26:5, pages 373-383.
Crossref
Frederik C. Enevoldsen, Jayashree Sahana, Markus Wehland, Daniela Grimm, Manfred Infanger & Marcus Krüger. (2020) Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy. Journal of Clinical Medicine 9:3, pages 824.
Crossref
Krishnamoorthy Karthika, Gangadharan Gargi, Senguttuvan Jamuna, Subramaniyam Paulsamy, Mohammad Ajmal Ali, Fahad Al-Hemaid, Mohamed Soliman Elshikh & Joongku Lee. (2019) The potential of antioxidant activity of methanolic extract of Coscinium fenestratum (Goetgh.) Colebr (Menispermaceae). Saudi Journal of Biological Sciences 26:5, pages 1037-1042.
Crossref
Andrea Sierra-Sepúlveda, Alexia Esquinca-González, Sergio A. Benavides-Suárez, Diego E. Sordo-Lima, Adrián E. Caballero-Islas, Antonio R. Cabral-Castañeda & Tatiana S. Rodríguez-Reyna. (2019) Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast. BioMed Research International 2019, pages 1-15.
Crossref
Tomohiko Takahashi, Satoru Hayata, Akihiro Kobayashi, Yuna Onaka, Takeshi Ebihara & Terufumi Hara. (2017) Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report). Clinical Drug Investigation 38:3, pages 219-229.
Crossref
Mariana Faria‐Urbina, Rudolf K.F. Oliveira, Sergio A. Segrera, Laurie Lawler, Aaron B. Waxman & David M. Systrom. (2018) Impaired systemic oxygen extraction in treated exercise pulmonary hypertension: a new engine in an old car?. Pulmonary Circulation 8:1, pages 1-4.
Crossref
Harish Jarrett & Christopher Barnett. (2017) HIV-associated pulmonary hypertension. Current Opinion in HIV and AIDS 12:6, pages 566-571.
Crossref
Belinda N. Rivera-Lebron & Michael G. Risbano. (2017) Ambrisentan: a review of its use in pulmonary arterial hypertension. Therapeutic Advances in Respiratory Disease 11:6, pages 233-244.
Crossref
Mi-Ma Duo-Ji & Zi-Wen Long. (2017) Comparative efficacy and acceptability of endothelin receptor antagonists for pulmonary arterial hypertension: A network meta-analysis. International Journal of Cardiology 234, pages 90-98.
Crossref
Paul Clift & David Celermajer. (2016) Managing adult Fontan patients: where do we stand?. European Respiratory Review 25:142, pages 438-450.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.